Answers are grounded in this paper and cite their sources.
Case report reveals severe phototoxic reaction in an 81-year-old with idiopathic pulmonary fibrosis, suggesting heightened awareness for dermatological risks.
This case report describes a phototoxic drug reaction in an 81-year-old patient taking the antifibrotic drug pirfenidone for the treatment of idiopathic pulmonary fibrosis. After two hours of sun exposure with sunscreen (SPF 50), the patient developed pruritic, erythematous and scaly lesions on the sun-exposed areas (face, neck, hands and forearms). Physical examination revealed an erythematous exanthema with coarse lamellar scale. A phototoxic reaction to pirfenidone was suspected based on the clinical presentation and distribution pattern. Treatment with topical corticosteroids and discontinuation of pirfenidone led to a marked improvement in symptoms. This case highlights the potential phototoxic risks of pirfenidone, which should be considered especially in dermatological practice where the drug is less known. In addition, important differential diagnoses are outlined and discussed.
No takes yet. Share an insight, caveat, or question.
Bode et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: